ARCHIVES

(8-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 05 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

In Brief: NCAB To Protest Tobacco Ads In ‘Family Circle’; ACS Petitions For Taxol Source Designation

October 19, 1990

Edward Benz Named President Of Dana-Farber Cancer Institute.

July 28, 2000

Cancer Education Applications Suspended Pending Restructuring

March 21, 1986

NCI Lists Projected Grant Paylines

February 16, 1996

Professional Societies: ASCO Foundation Formed to Support Fellowship Awards

June 11, 1999